Idexx Laboratories, Inc. Earnings

Idexx Laboratories, Inc.’s revenue jumped 6.56% since last year same period to $975.54Mn in the Q3 2024. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -2.79% fall in its revenue since last 3-months.

Idexx Laboratories, Inc.’s net profit jumped 9.71% since last year same period to $232.84Mn in the Q3 2024. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 14.53% jump in its net profits since last 3-months.

Idexx Laboratories, Inc.’s net profit margin jumped 2.96% since last year same period to 23.87% in the Q3 2024. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 17.82% jump in its net profit margins since last 3-months.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.68 - a -6.94% fall from last quarter’s estimates.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 2.68.

Idexx Laboratories, Inc.’s earning per share (EPS) jumped 10.67% since last year same period to 2.8 in the Q3 2024. This indicates that the Idexx Laboratories, Inc. has generated 10.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.